Parnax Lab Limited

BSE:506128 Voorraadrapport

Marktkapitalisatie: ₹1.7b

Parnax Lab Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Parnax Lab has a total shareholder equity of ₹716.9M and total debt of ₹806.4M, which brings its debt-to-equity ratio to 112.5%. Its total assets and total liabilities are ₹1.9B and ₹1.2B respectively. Parnax Lab's EBIT is ₹184.7M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹18.8M.

Belangrijke informatie

112.5%

Verhouding schuld/eigen vermogen

₹806.39m

Schuld

Rente dekkingsratio3.2x
Contant₹18.77m
Aandelen₹716.95m
Totaal verplichtingen₹1.17b
Totaal activa₹1.89b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 506128's short term assets (₹754.3M) do not cover its short term liabilities (₹818.3M).

Langlopende schulden: 506128's short term assets (₹754.3M) exceed its long term liabilities (₹352.4M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 506128's net debt to equity ratio (109.9%) is considered high.

Schuld verminderen: 506128's debt to equity ratio has increased from 104.1% to 112.5% over the past 5 years.

Schuldendekking: 506128's debt is not well covered by operating cash flow (19.7%).

Rentedekking: 506128's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balans


Ontdek gezonde bedrijven